Figure 2
From: Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy

Effect of ICB and bacterial metabolites cell viability in immune cell organoids. (a) ATP production was measured via CellTiter-Glo 3D™ for untreated CRL organoids, metabolite treated organoids, ICB treated organoids, and organoids that received a combination of both treatments (n = 4). (b) H&E stained splenocytes organoid (arrow indicates splenocyte. 20 × magnification, inset 4 × magnification).